← Leaderboards
Jeff Mark Herz
Algomedix, Inc.
$1,951,825
Attributed
$1,951,825
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2011–17$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,951,825 · 5
By mechanism
R43$1,217,510 · 4
R44$734,315 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantDoseResponseBaseRattusIn VitroPharmaceutical PreparationsReceptorTrp ChannelPharmacologyPropertyLeadProgram DevelopmentIn VivoIon ChannelAgonistCellsPhysiologicalNociceptorsPainNeuronsOralNociceptionPharmaceutical Chemistry
Grant awards (5)
Development of a TRPA1 Antagonist Opioid-Sparing Analgesic for Chronic Pain$734,315
R44 · FY2017 · DA · contact PI
Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain$291,147
R43 · FY2017 · CA · contact PI
TRPC6 Antagonists as Therapeutics for Chronic Kidney Disease$296,818
R43 · FY2015 · DK · contact PI
Control of Arthritic Pain by Inhibition of TRPA1 Activity$313,424
R43 · FY2013 · AR · contact PI
Analgesics Targeting TRPA1 for Treatment of Chronic Pain$316,121
R43 · FY2011 · DA · contact PI